Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Fosun Says its M&A/Operating Strategy Designed to Meet Next-Gen Business World

publication date: Apr 4, 2017
In an annual letter to shareholders, China conglomerate Fosun International, the parent of Fosun Pharma, said its heavy use of M&A is designed to promote two linked goals: C2M and a closed loop. C2M (customer-to-maker) describes the internet world that has, in many cases, done away with intermediaries, allowing customers to talk directly to companies -- and vice-versa with targeted advertising. The closed loop is a result of C2M, allowing a company to dominate the varied stages of a particular industry. It is especially evident in healthcare. For Fosun, the closed loop includes health insurance, health management, healthcare delivery, pharmaceutical drugs and medical devices. Fosun is active in each segment. More details....

Stock Symbols: (HK: 0656) (SHA: 600196; HK: 2196)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here